Objective: To review recent research findings on tardive dyskinesia (T
D) with relevance to clinical practice. Method: TD is a syndrome of in
voluntary movements that can occur in association with chronic neurole
ptic use. It is of unknown pathophysiology. It can be irreversible, is
cosmetically disfiguring, and can be functionally disabling. Results:
There is as yet no treatment of demonstrated efficacy for TD. It is a
n iatrogenic disorder whose incidence is increased by age and total cu
mulative dose of typical neuroleptics. If has been the source of succe
ssful litigation in some jurisdictions but until very recently, there
has been no effective antipsychotic agent without this effect Conclusi
on: This litigation in some jurisdictions has been a major impetus to
the development of novel antipsychotic agents. If is less well known t
hat a similar, possibly identical, movement disorder occurs spontaneou
sly particularly in the elderly and inpatients with schizophrenia, and
that TD is often reversible.